Swedish Orphan Biovitrum AB (OTCPK:BIOVF)
$ 31.38 -0.63 (-1.97%) Market Cap: 10.19 Bil Enterprise Value: 12.00 Bil PE Ratio: 31.90 PB Ratio: 3.01 GF Score: 90/100

Swedish Orphan Biovitrum AB (publ) KOL Haemophilia Call (Virtual) Transcript

Sep 18, 2023 / 01:00PM GMT
Release Date Price: $19.95
Operator

Ladies and gentlemen, welcome to the Advanced under Standard of Care in Hemophilia Conference Call and Live Webcast. I am Alice, the Chorus Call operator. (Operator Instructions).

At this time, it's my pleasure to hand over to Guido Oelkers, Chief Executive Officer. Please go ahead, sir.

Guido Oelkers;publ;CEO;President
Swedish Orphan Biovitrum AB

()-&

Thank you so much, and good afternoon, respectively, good morning to this event. Let's say, it's really a great pleasure to have you all with you the sequence of events after our last event on (inaudible) very excited about it. And maybe move to the next slide, which is a forward-looking statement as per usual. Today, I'm joined by Lydia Adad who is our acting Chief Medical Officer and who will be clinical efficacy and safety of efanesoctocog alfa. I'm really delighted also to have to welcome Dr. Robert Klamroth, who is Head of Internal Medicine at the hemophilia comprehensive care center, Vivantes in Berlin, Germany. And he is not only one of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot